ArticleScience progress
Prevalence and outcomes of acute kidney injury in cirrhotic patients admitted to the intensive care unit: A 16-year retrospective cohort study in Saudi Arabia.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveAcute kidney injury (AKI) in patients with cirrhosis is associated with increased morbidity and mortality in critically ill patients. There is a considerable variation in the reported prevalence of AKI across studies. We provide a unique regional analysis, addressing gaps in AKI data in critically ill cirrhotic patients from the Middle East.MethodsIn this single-center, retrospective cohort study, we included all patients known to have liver cirrhosis admitted to our tertiary care center over 16 years. Data was extracted from the existing database in the intensive care unit (ICU) department at King Abdulaziz Medical City, Riyadh, Saudi Arabia. Subjects were categorized into four groups using the Kidney Disease Improving Global Outcomes criteria. We evaluated the prevalence of AKI and its association on the in-hospital mortality.ResultsFrom 2002 to 2017, 1197 cirrhotic patients were admitted to our ICU. Among them, 68 (5.7%) had stage 1 AKI, 193 (16.1%) had stage 2 AKI, 475 (39.8%) had stage 3 AKI. Overall, in-hospital mortality was progressively higher with worsening severity of AKI, from non-AKI (42.0%) to stage 3 AKI (72.2%),
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.